| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4250868
Max Phase: Preclinical
Molecular Formula: C22H20N6O2S
Molecular Weight: 432.51
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc2c(OCc3nnc4sc(-c5ccn(CC6CC6)c5)nn34)ccnc2c1
Standard InChI: InChI=1S/C22H20N6O2S/c1-29-16-4-5-17-18(10-16)23-8-6-19(17)30-13-20-24-25-22-28(20)26-21(31-22)15-7-9-27(12-15)11-14-2-3-14/h4-10,12,14H,2-3,11,13H2,1H3
Standard InChI Key: BVVKEHRJVHTZJC-UHFFFAOYSA-N
Associated Targets(Human)
SNU-5 270 Activities
Hepatocyte growth factor receptor 10718 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MKN-45 2102 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EBC-1 148 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 432.51 | Molecular Weight (Monoisotopic): 432.1368 | AlogP: 4.20 | #Rotatable Bonds: 7 |
| Polar Surface Area: 79.36 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 6.17 | CX LogP: 3.57 | CX LogD: 3.55 |
| Aromatic Rings: 5 | Heavy Atoms: 31 | QED Weighted: 0.38 | Np Likeness Score: -1.70 |
References
| 1. Zhang L, Zhao J, Zhang B, Lu T, Chen Y.. (2018) Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity., 150 [PMID:29602036] [10.1016/j.ejmech.2018.03.049] |
Source
Source(1):